Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Breast Cancer Research : BCR
|
May 24, 2024
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
Lujia Chen, Ying Wang, Chunhui Cai, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 4, 2014
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling
Lajos Markó, Norbert Henke, Joon-Keun Park, et al.
NPJ Breast Cancer
|
July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
Kevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial
Priya Rastogi, Hanna Bandos, Peter C Lucas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2025
Erratum: Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
Lujia Chen, Ying Wang, Chunhui Cai, et al.
Breast Cancer Research : BCR
|
April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression
Juliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Cell Reports
|
September 30, 2016
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage
Linda R Klei, Dong Hu, Robert Panek, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu, Jessica L Narloch, Sayali Onkar, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Breast Cancer Research : BCR
|
May 24, 2024
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
Lujia Chen, Ying Wang, Chunhui Cai, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 4, 2014
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling
Lajos Markó, Norbert Henke, Joon-Keun Park, et al.
NPJ Breast Cancer
|
July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
Kevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial
Priya Rastogi, Hanna Bandos, Peter C Lucas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2025
Erratum: Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer
Lujia Chen, Ying Wang, Chunhui Cai, et al.
Breast Cancer Research : BCR
|
April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Samuel A Jacobs, Ying Wang, Jame Abraham, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression
Juliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Cell Reports
|
September 30, 2016
MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage
Linda R Klei, Dong Hu, Robert Panek, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2019
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu, Jessica L Narloch, Sayali Onkar, et al.
Page
of 12